Academic Journal

Ginkgo biloba for tinnitus

التفاصيل البيبلوغرافية
العنوان: Ginkgo biloba for tinnitus
المؤلفون: Sereda, M., Xia, J., Scutt, P., Hilton, M. P., El Refaie, A., Hoare, D. J.
بيانات النشر: Wiley
سنة النشر: 2023
المجموعة: RD&E Research Repository (Royal Devon and Exeter NHS Foundation Trust)
مصطلحات موضوعية: Adult, Child, Humans, Ginkgo biloba, Headache, Hypersensitivity, Seizures, Tinnitus/therapy, Randomized Controlled Trials as Topic
الوصف: BACKGROUND: Tinnitus is a symptom defined as the perception of sound in the absence of an external source. In England alone there are an estimated ¾ million general practice consultations every year where the primary complaint is tinnitus, equating to a major burden on healthcare services. Clinical management strategies include education and advice, relaxation therapy, tinnitus retraining therapy (TRT), cognitive behavioural therapy (CBT), sound enrichment using ear-level sound generators or hearing aids, and drug therapies to manage co-morbid symptoms such as insomnia, anxiety or depression. OBJECTIVES: To assess the effects of Ginkgo biloba for tinnitus in adults and children. SEARCH METHODS: The Cochrane ENT Information Specialist searched the Cochrane ENT Register; CENTRAL (2022, Issue 6); Ovid MEDLINE; Ovid Embase; CINAHL; Web of Science; ClinicalTrials.gov; ICTRP and additional sources for published and unpublished trials. The date of the search was 7 June 2022. SELECTION CRITERIA: Randomised controlled trials (RCTs) recruiting adults and children with acute or chronic subjective tinnitus. We included studies where the intervention involved Ginkgo biloba and this was compared to placebo, no intervention, or education and information. Concurrent use of other medication or other treatment was acceptable if used equally in each group. Where an additional intervention was used equally in both groups, we analysed this as a separate comparison. The review included all courses of Ginkgo biloba, regardless of dose regimens or formulations, and for any duration of treatment. DATA COLLECTION AND ANALYSIS: We used standard Cochrane methods. Our primary outcomes were tinnitus symptom severity measured as a global score on a multi-item tinnitus questionnaire and serious adverse effects (bleeding, seizures). Our secondary outcomes were tinnitus loudness (change in subjective perception), tinnitus intrusiveness, generalised depression, generalised anxiety, health-related quality of life and other adverse effects ...
نوع الوثيقة: article in journal/newspaper
اللغة: English
Relation: https://doi.org/10.1002/14651858.CD013514.pub2; Cochrane Database Syst Rev. 2022 Nov 16;11(11):CD013514. doi:10.1002/14651858.CD013514.pub2.; The Cochrane database of systematic reviews; PMC9668350 Society of Audiology Tinnitus and Hyperacusis Special Interest Group and Associate Editor for the International Journal of Audiology and BMC Health Services Research. She is funded by the NIHR Nottingham Biomedical Research Centre. She has received tinnitus research funding from the British Tinnitus Association, the British Society of Audiology and the NIHR. Jun Xia: none known. Polly Scutt: none known. Malcolm Hilton: none known. Amr El Refaie: none known. Derek J Hoare: DJH is Editor‐at‐large for Ear and Hearing and Chair of the British Society of Audiology. He is funded by the NIHR and research lead for hearing at the NIHR Nottingham Biomedical Research Centre. He has received tinnitus research funding from the British Society of Audiology, the British Tinnitus Association, RNID, Horizon 2020, Royal British Legion, Help Musicians UK and the NIHR.; https://hdl.handle.net/11287/622759
DOI: 10.1002/14651858.CD013514.pub2
الاتاحة: https://hdl.handle.net/11287/622759
https://doi.org/10.1002/14651858.CD013514.pub2
Rights: Copyright © 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ; http://creativecommons.org/publicdomain/zero/1.0/
رقم الانضمام: edsbas.7ABC7F0D
قاعدة البيانات: BASE
الوصف
DOI:10.1002/14651858.CD013514.pub2